Ellen AB Logo

Ellen AB

Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.

ELN | ST

Overview

Corporate Details

ISIN(s):
SE0014730347
LEI:
549300KJGSYJ46ZTZ557
Country:
Sweden
Address:
Barnhusgatan 4 ög nv, 111 23 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ellen AB is a biotechnology and Fem-Tech company, founded in 2000, that specializes in women's intimate health. The company develops and markets a range of innovative and natural products designed to maintain a healthy pH balance for women throughout all stages of life, including menstruation, pregnancy, and menopause. Ellen's offerings are grounded in scientific research and its portfolio includes products such as probiotic tampons, which contain the patented strain of lactic acid bacteria Lacto Naturel (LN), as well as prebiotic cleansers, probiotic creams, and vaginal pH tests. The company's mission is to provide effective, research-based solutions that contribute to women's well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ellen AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ellen AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ellen AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

PALISADE BIO, INC. Logo
Developing oral precision therapies for inflammatory and fibrotic intestinal diseases like colitis.
United States of America
PALI
PALVELLA THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing topical therapies for rare genetic skin diseases.
United States of America
PVLA
Pangen Biotech Inc. Logo
Develops biosimilars and provides CHO-based CDMO services for the global biopharma industry.
South Korea
222110
PCI Biotech Holding Logo
Biopharma firm evaluating its future after discontinuing its core technology development.
Norway
PCIB
Pelthos Therapeutics Inc. Logo
Biopharma with an approved gel for molluscum, advancing a nitric oxide-based pipeline.
United States of America
PTHS
Pentixapharm Holding AG Logo
Develops radiopharmaceuticals for diagnosing and treating oncology and adrenal disorders.
Germany
PTP
PeopleBio, Inc. Logo
Develops blood tests for early diagnosis of neurodegenerative diseases like Alzheimer's.
South Korea
304840
PeptiDream Inc. Logo
Discovers peptide therapeutics via a proprietary platform and markets radiopharmaceuticals.
Japan
4587
PEPTONIC Medical AB Logo
Develops clinically proven self-care products for women's intimate health.
Sweden
PMED
Develops sustained-release peptide medicines for chronic & neurodegenerative disorders.
South Korea
087010

Talk to a Data Expert

Have a question? We'll get back to you promptly.